Cite
Anti-SIRP α antibodies as a potential new tool for cancer immunotherapy.
MLA
Yanagita, Tadahiko, et al. “Anti-SIRP α Antibodies as a Potential New Tool for Cancer Immunotherapy.” JCI Insight, vol. 2, no. 1, Jan. 2017, p. e89140. EBSCOhost, https://doi.org/10.1172/jci.insight.89140.
APA
Yanagita, T., Murata, Y., Tanaka, D., Motegi, S.-I., Arai, E., Daniwijaya, E. W., Hazama, D., Washio, K., Saito, Y., Kotani, T., Ohnishi, H., Oldenborg, P.-A., Garcia, N. V., Miyasaka, M., Ishikawa, O., Kanai, Y., Komori, T., & Matozaki, T. (2017). Anti-SIRP α antibodies as a potential new tool for cancer immunotherapy. JCI Insight, 2(1), e89140. https://doi.org/10.1172/jci.insight.89140
Chicago
Yanagita, Tadahiko, Yoji Murata, Daisuke Tanaka, Sei-Ichiro Motegi, Eri Arai, Edwin Widyanto Daniwijaya, Daisuke Hazama, et al. 2017. “Anti-SIRP α Antibodies as a Potential New Tool for Cancer Immunotherapy.” JCI Insight 2 (1): e89140. doi:10.1172/jci.insight.89140.